These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29535522)
21. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients. Cao Y; Liu X; Xu H Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989 [TBL] [Abstract][Full Text] [Related]
22. Vitamin K deficiency, evaluated with higher serum ucOC, was correlated with poor bone status in women. Tanaka N; Arima K; Nishimura T; Tomita Y; Mizukami S; Okabe T; Abe Y; Kawashiri SY; Uchiyama M; Honda Y; Tsujimoto R; Kanagae M; Osaki M; Aoyagi K J Physiol Anthropol; 2020 Apr; 39(1):9. PubMed ID: 32276651 [TBL] [Abstract][Full Text] [Related]
23. Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid. Kasai H; Mori Y; Ose A; Shiraki M; Tanigawara Y J Clin Pharmacol; 2021 May; 61(5):606-613. PubMed ID: 33135182 [TBL] [Abstract][Full Text] [Related]
24. Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis. Furukawa M; Okuyama K; Ninomiya K; Miyamoto T; Yato Y Spine Surg Relat Res; 2022 Sep; 6(5):526-532. PubMed ID: 36348678 [TBL] [Abstract][Full Text] [Related]
25. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156 [TBL] [Abstract][Full Text] [Related]
26. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Liu G; Peacock M Calcif Tissue Int; 1998 Apr; 62(4):286-9. PubMed ID: 9504950 [TBL] [Abstract][Full Text] [Related]
27. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. Szulc P; Arlot M; Chapuy MC; Duboeuf F; Meunier PJ; Delmas PD J Bone Miner Res; 1994 Oct; 9(10):1591-5. PubMed ID: 7817805 [TBL] [Abstract][Full Text] [Related]
28. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. Indridason OS; Franzson L; Sigurdsson G Osteoporos Int; 2005 Apr; 16(4):417-23. PubMed ID: 15776220 [TBL] [Abstract][Full Text] [Related]
29. Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women. Emaus N; Nguyen ND; Almaas B; Berntsen GK; Center JR; Christensen M; Gjesdal CG; Grimsgaard AS; Nguyen TV; Salomonsen L; Eisman JA; Fønnebø VM Eur J Nutr; 2013 Feb; 52(1):49-55. PubMed ID: 22127508 [TBL] [Abstract][Full Text] [Related]
30. Bone Mineral Density and Physical Performance of Female Patients 27 Years or Longer after Surgery for Adolescent Idiopathic Scoliosis. Akazawa T; Kotani T; Sakuma T; Katogi T; Minami S; Niki H; Torii Y; Morioka S; Orita S; Inage K; Fujimoto K; Shiga Y; Takahashi K; Ohtori S Asian Spine J; 2017 Oct; 11(5):780-786. PubMed ID: 29093789 [TBL] [Abstract][Full Text] [Related]
31. Association between vitamin K intake from fermented soybeans, natto, and bone mineral density in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Fujita Y; Iki M; Tamaki J; Kouda K; Yura A; Kadowaki E; Sato Y; Moon JS; Tomioka K; Okamoto N; Kurumatani N Osteoporos Int; 2012 Feb; 23(2):705-14. PubMed ID: 21394493 [TBL] [Abstract][Full Text] [Related]
32. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Aonuma H; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y Tohoku J Exp Med; 2009 Jul; 218(3):201-5. PubMed ID: 19561390 [TBL] [Abstract][Full Text] [Related]
33. Alcohol intake and bone status in elderly Japanese men: baseline data from the Fujiwara-kyo osteoporosis risk in men (FORMEN) study. Kouda K; Iki M; Fujita Y; Tamaki J; Yura A; Kadowaki E; Sato Y; Moon JS; Morikawa M; Tomioka K; Okamoto N; Kurumatani N Bone; 2011 Aug; 49(2):275-80. PubMed ID: 21530699 [TBL] [Abstract][Full Text] [Related]
34. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide. Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190 [TBL] [Abstract][Full Text] [Related]
35. Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry. Tokida R; Uehara M; Nakano M; Suzuki T; Sakai N; Ikegami S; Takahashi J; Nakamura Y; Kato H Sci Rep; 2021 Apr; 11(1):7822. PubMed ID: 33837266 [TBL] [Abstract][Full Text] [Related]
36. Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide. Okamura T; Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Yamashima M; Yamamichi S; Koike M; Nakano Y; Honda T; Yajima H; Miyazaki O; Kuribayashi Y; Ikeda T; Taura N; Nakao K Biomed Rep; 2022 Jan; 16(1):6. PubMed ID: 34900255 [TBL] [Abstract][Full Text] [Related]
37. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491 [TBL] [Abstract][Full Text] [Related]
38. The combined effect of vitamin K and calcium on bone mineral density in humans: a meta-analysis of randomized controlled trials. Hu L; Ji J; Li D; Meng J; Yu B J Orthop Surg Res; 2021 Oct; 16(1):592. PubMed ID: 34649591 [TBL] [Abstract][Full Text] [Related]
39. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. Vergnaud P; Garnero P; Meunier PJ; Bréart G; Kamihagi K; Delmas PD J Clin Endocrinol Metab; 1997 Mar; 82(3):719-24. PubMed ID: 9062471 [TBL] [Abstract][Full Text] [Related]
40. Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study. Tominaga A; Wada K; Kato Y; Nishi H; Terayama Y; Okazaki K Osteoporos Int; 2021 Apr; 32(4):653-661. PubMed ID: 32979066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]